Skip to content
Bomb Report – Lifestyle
Author:
Insilico Medicine
Insilico Medicine to Announce 2025 Financial Results on March 30, 2026
March 13, 2026
Insilico and TaiGen Achieve Milestone in Collaboration: Out-Licensed CKD Anemia Candidate ISM4808 Completes first human enrollment and dosing in Phase I clinical trial
March 7, 2026
Insilico Medicine and Liquid AI Announce Strategic Partnership Delivering Lightweight Scientific Foundation Models for Drug Discovery
March 6, 2026
Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies
March 5, 2026
←
Previous Page
1
2